atai Life Sciences

Atai Life Sciences is a German biopharmaceutical company founded in 2018 with a clear mission in mind - "Healing mental health disorders so that everyone, everywhere can live a more fulfilled life." The company takes a unique approach by leveraging a decentralized platform to incubate and accelerate the development of highly effective mental health treatments. This strategy allows atai to address the unmet needs of patients while pooling expertise, best practices, and resources across its entire portfolio. The ultimate vision is to provide accessible and impactful treatments to improve mental well-being globally. Currently, there is no specific information available on the last investment or the investors involved in atai Life Sciences.